Brief: Island Pharmaceuticals Signs Non-Binding Term Sheet With Biocryst
03/07/2024 02:09
July 3 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* SIGNS NON-BINDING TERM SHEET WITH BIOCRYST
Further company coverage: ILA.AX
Recent news on BioCryst Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
Brief: Biocryst Announces Approval Of Orladeyo® For Pediatric Hae Patients In Japan
BioCryst Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Biocryst Pharmaceuticals, - Cash, Cash Equivalents, Restricted Cash And Investments $354 Million At June 30, 2026